Relation of completeness of reporting of health research to journals’ endorsement of reporting guidelines: systematic review

Objective To assess whether the completeness of reporting of health research is related to journals’ endorsement of reporting guidelines. Design Systematic review. Data sources Reporting guidelines from a published systematic review and the EQUATOR Network (October 2011). Studies assessing the completeness of reporting by using an included reporting guideline (termed “evaluations”) (1990 to October 2011; addendum searches in January 2012) from searches of either Medline, Embase, and the Cochrane Methodology Register or Scopus, depending on reporting guideline name. Study selection English language reporting guidelines that provided explicit guidance for reporting, described the guidance development process, and indicated use of a consensus development process were included. The CONSORT statement was excluded, as evaluations of adherence to CONSORT had previously been reviewed. English or French language evaluations of included reporting guidelines were eligible if they assessed the completeness of reporting of studies as a primary intent and those included studies enabled the comparisons of interest (that is, after versus before journal endorsement and/or endorsing versus non-endorsing journals). Data extraction Potentially eligible evaluations of included guidelines were screened initially by title and abstract and then as full text reports. If eligibility was unclear, authors of evaluations were contacted; journals’ websites were consulted for endorsement information where needed. The completeness of reporting of reporting guidelines was analyzed in relation to endorsement by item and, where consistent with the authors’ analysis, a mean summed score. Results 101 reporting guidelines were included. Of 15 249 records retrieved from the search for evaluations, 26 evaluations that assessed completeness of reporting in relation to endorsement for nine reporting guidelines were identified. Of those, 13 evaluations assessing seven reporting guidelines (BMJ economic checklist, CONSORT for harms, PRISMA, QUOROM, STARD, STRICTA, and STROBE) could be analyzed. Reporting guideline items were assessed by few evaluations. Conclusions The completeness of reporting of only nine of 101 health research reporting guidelines (excluding CONSORT) has been evaluated in relation to journals’ endorsement. Items from seven reporting guidelines were quantitatively analyzed, by few evaluations each. Insufficient evidence exists to determine the relation between journals’ endorsement of reporting guidelines and the completeness of reporting of published health research reports. Journal editors and researchers should consider collaborative prospectively designed, controlled studies to provide more robust evidence. Systematic review registration Not registered; no known register currently accepts protocols for methodology systematic reviews.

[1]  R. Morris,et al.  The quality of reporting of primary test accuracy studies in obstetrics and gynaecology: application of the STARD criteria , 2011, BMC women's health.

[2]  Iveta Simera,et al.  Describing reporting guidelines for health research: a systematic review. , 2011, Journal of clinical epidemiology.

[3]  David Moher,et al.  Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. , 2012, The Cochrane database of systematic reviews.

[4]  A. Booth,et al.  Do health technology assessments comply with QUOROM diagram guidance? An empirical study , 2007, BMC medical research methodology.

[5]  J. Achten,et al.  A systematic survey of the quality of research reporting in general orthopaedic journals. , 2011, The Journal of bone and joint surgery. British volume.

[6]  J. Mahoney,et al.  Assessing the quality of glucose monitor studies: a critical evaluation of published reports. , 2007, Clinical chemistry.

[7]  Curtis L. Meinert,et al.  A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group. , 1994, JAMA.

[8]  Jill Hayden,et al.  Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. , 2005, Journal of clinical epidemiology.

[9]  J. Ellison,et al.  Good publication practice for communicating company sponsored medical research: the GPP2 guidelines , 2009, BMJ : British Medical Journal.

[10]  A. Azuara-Blanco,et al.  The quality of reporting of diagnostic accuracy studies of optical coherence tomography in glaucoma. , 2007, Ophthalmology.

[11]  David Moher,et al.  Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement , 2006, Annals of Internal Medicine.

[12]  D. Rennie,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.

[13]  J. Ioannidis,et al.  Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement , 2004, Annals of Internal Medicine.

[14]  Myeong Soo Lee,et al.  Assessment of the quality of reporting for treatment components in Cochrane reviews of acupuncture , 2014, BMJ Open.

[15]  U. Bergman,et al.  Guidelines for submitting adverse event reports for publication , 2007, Drug safety.

[16]  T O Jefferson,et al.  Guidelines for authors and peer reviewers of economic submissions to the BMJ , 1996, BMJ.

[17]  Apa Publications,et al.  Reporting standards for research in psychology: why do we need them? What might they be? , 2008, The American psychologist.

[18]  Milton C. Weinstein,et al.  Recommendations for Reporting Cost-effectiveness Analyses , 1996 .

[19]  Sunil V. Rao,et al.  Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group. , 2009, American heart journal.

[20]  Peter Woollard,et al.  The minimum information required for reporting a molecular interaction experiment (MIMIx) , 2007, Nature Biotechnology.

[21]  Jill J. Francis,et al.  Designing theoretically-informed implementation interventions , 2006, Implementation science : IS.

[22]  P. Scuffham,et al.  Guidelines for conducting and reporting economic evaluation of fall prevention strategies , 2011, Osteoporosis International.

[23]  E. Chen,et al.  Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  I. Tannock,et al.  Quality of abstracts describing randomized trials in the proceedings of American Society of Clinical Oncology meetings: guidelines for improved reporting. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  M. Hazinski,et al.  Recommended guidelines for uniform reporting of pediatric advanced life support: the pediatric Utstein style. , 1995, Annals of emergency medicine.

[26]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[27]  Benjamin M Craig,et al.  Bmc Complementary and Alternative Medicine Is Complementary and Alternative Medicine (cam) Cost-effective? a Systematic Review , 2004 .

[28]  David Gavaghan,et al.  Using evidence from different sources : an example using paracetamol 1000 mg plus codeine 60 mg , 2001 .

[29]  M. Ritskes-Hoitinga,et al.  A Gold Standard Publication Checklist to Improve the Quality of Animal Studies, to Fully Integrate the Three Rs, and to Make Systematic Reviews More Feasible , 2010, Alternatives to laboratory animals : ATLA.

[30]  J. Ioannidis,et al.  Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement , 2009, European Journal of Epidemiology.

[31]  J. Grimshaw,et al.  Intracluster correlation coefficients in cluster randomized trials: empirical insights into how should they be reported , 2004, BMC medical research methodology.

[32]  Martin P. Ward,et al.  The REFLECT Statement: Methods and Processes of Creating Reporting Guidelines for Randomized Controlled Trials for Livestock and Food Safety by Modifying the CONSORT Statement † , 2010, Zoonoses and public health.

[33]  Designing theoretically-informed implementation interventions The Improved Clinical Effectiveness through Behavioural Research Group ( ICEBeRG ) * , 2022 .

[34]  Sunila R. Kalkar,et al.  Financial Conflicts of Interest Checklist 2010 for clinical research studies , 2010, Open medicine : a peer-reviewed, independent, open-access journal.

[35]  Petter Andreas Steen,et al.  Recommended guidlines for reviewing, reporting, and conducting research on in-hospital resuscitation: The in-hospital 'Utstein style' , 1997 .

[36]  Chris F. Taylor,et al.  Guidelines for reporting the use of mass spectrometry in proteomics , 2008, Nature Biotechnology.

[37]  J. Karp,et al.  From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. , 1990, The Journal of infectious diseases.

[38]  F. Vermassen,et al.  A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. , 2007, European heart journal.

[39]  P. Bossuyt,et al.  Quality of reporting of test accuracy studies in reproductive medicine: impact of the Standards for Reporting of Diagnostic Accuracy (STARD) initiative. , 2006, Fertility and sterility.

[40]  D. Moher,et al.  Consolidated Standards for Reporting Trials of Traditional Chinese Medicine (CONSORT for TCM) (For Solicitation of Comments) , 2007 .

[41]  R. Rutherford,et al.  Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. , 1986, Journal of vascular surgery.

[42]  J. Roujeau,et al.  Impact of STROBE Statement Publication on Quality of Observational Study Reporting: Interrupted Time Series versus Before-After Analysis , 2013, PloS one.

[43]  C. Bloomfield,et al.  Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  R. Elliott,et al.  Evolving guidelines for publication of qualitative research studies in psychology and related fields. , 1999, The British journal of clinical psychology.

[45]  C. Gamble,et al.  Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension , 2013, BMJ Open.

[46]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[47]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.

[48]  T. Aufderheide,et al.  Standardized reporting guidelines for studies evaluating risk stratification of emergency department patients with potential acute coronary syndromes. , 2004, Annals of emergency medicine.

[49]  D. Moher,et al.  Does journal endorsement of reporting guidelines influence the completeness of reporting of health research? A systematic review protocol , 2012, Systematic Reviews.

[50]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[51]  K. Jobst,et al.  Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT , 2007, Homeopathy.

[52]  K. Jobst,et al.  Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. , 2001, Complementary therapies in medicine.

[53]  Thorsten Henrich,et al.  Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE) , 2008, Nature Biotechnology.

[54]  J. Nolan,et al.  Recommended guidelines for reviewing, reporting, and conducting research on post-resuscitation care: the Utstein style. , 2005, Resuscitation.

[55]  S Nahum Goldberg,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria. , 2005, Radiology.

[56]  Laura Smith,et al.  Best Practices in the Reporting of Participatory Action Research: Embracing Both the Forest and the Trees 1Ψ7 , 2010 .

[57]  N. Heddle,et al.  A systematic assessment of the quality of reporting for platelet transfusion studies , 2010, Transfusion.

[58]  M C Weinstein,et al.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[59]  Mikel Aickin,et al.  Randomized Controlled Trials of Acupuncture (1997–2007): An Assessment of Reporting Quality with a CONSORT- and STRICTA-Based Instrument , 2010, Evidence-based complementary and alternative medicine : eCAM.

[60]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[61]  J. Overton,et al.  Recommended guidelines for reporting on emergency medical dispatch when conducting research in emergency medicine: the Utstein style. , 2008, Resuscitation.

[62]  BlueCross BlueShield.  Special report: measuring and reporting pain outcomes in randomized controlled trials. , 2006, Technology Evaluation Center Assessment Program. Executive summary.

[63]  K. Wüthrich,et al.  Recommendations for the presentation of NMR structures of proteins and nucleic acids – IUPAC-IUBMB-IUPAB Inter-Union Task Group on the Standardization of Data Bases of Protein and Nucleic Acid Structures Determined by NMR Spectroscopy , 1998, European journal of biochemistry.

[64]  D. Altman,et al.  Are Peer Reviewers Encouraged to Use Reporting Guidelines? A Survey of 116 Health Research Journals , 2012, PloS one.

[65]  R O Cummins,et al.  Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. Task Force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. , 1991, Annals of emergency medicine.

[66]  S. Ghimire,et al.  Oncology trial abstracts showed suboptimal improvement in reporting: a comparative before-and-after evaluation using CONSORT for Abstract guidelines. , 2014, Journal of clinical epidemiology.

[67]  Kaisra Esmail,et al.  Association of study quality with completeness of reporting: have completeness of reporting and quality of systematic reviews and meta-analyses in major radiology journals changed since publication of the PRISMA statement? , 2013, Radiology.

[68]  A. Dobson,et al.  Quality of reporting of observational longitudinal research. , 2005, American journal of epidemiology.

[69]  D. Moher,et al.  Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors' , 2008, Trials.

[70]  A. Harris,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British Journal of Cancer.

[71]  P. Rochon,et al.  Published randomized controlled trials of drug therapy for dementia often lack complete data on harm. , 2008, Journal of clinical epidemiology.

[72]  David R. Smith,et al.  Consensus-based reporting standards for diagnostic test accuracy studies for paratuberculosis in ruminants. , 2011, Preventive veterinary medicine.

[73]  F. Morrison.  Exercise Therapy and Low Back Pain: Insights and Proposals to Improve the Design, Conduct, and Reporting of Clinical Trials , 2013, physioscience.

[74]  S. Ayis,et al.  Adverse event reporting in randomised controlled trials of neuropathic pain: Considerations for future practice , 2013, PAIN.

[75]  D. Moher,et al.  The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.

[76]  H. D. de Vet,et al.  Endorsement of the STARD Statement by biomedical journals: survey of instructions for authors. , 2007, Clinical chemistry.

[77]  W. Dixon,et al.  EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology , 2010, Annals of the rheumatic diseases.

[78]  R. Lüdtke,et al.  Reporting experiments in homeopathic basic research (REHBaR) – A detailed guideline for authors , 2009, Homeopathy.

[79]  Lennart Martens,et al.  The minimum information about a proteomics experiment (MIAPE) , 2007, Nature Biotechnology.

[80]  David Moher,et al.  Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement , 2010, PLoS medicine.

[81]  Walter Ricciardi,et al.  Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses , 2013, PloS one.

[82]  L. Krzych,et al.  No improvement in studies reporting the diagnostic accuracy of B-type natriuretic peptide. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[83]  P. Bossuyt,et al.  The quality of diagnostic accuracy studies since the STARD statement , 2006, Neurology.

[84]  Julie Glanville,et al.  How to formulate research recommendations , 2006, BMJ : British Medical Journal.

[85]  M. Bettmann,et al.  Guidelines for the Reporting of Renal Artery Revascularization in Clinical Trials , 2002, Journal of vascular and interventional radiology : JVIR.

[86]  Nigel W. Hardy,et al.  Summary recommendations for standardization and reporting of metabolic analyses , 2005, Nature Biotechnology.

[87]  J. Hammon,et al.  Consensus Statement : Minimal Criteria for Reporting the Systemic Inflammatory Response to Cardiopulmonary Bypass , 2011 .

[88]  M. Hallett,et al.  Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD) , 2010, Movement disorders : official journal of the Movement Disorder Society.

[89]  Daniel Morton,et al.  Best Practices for Reporting Pathology Interpretations within GLP Toxicology Studies , 2006, Toxicologic pathology.

[90]  Kevin W Plaxco,et al.  Protein folding: Defining a “standard” set of experimental conditions and a preliminary kinetic data set of two‐state proteins , 2005, Protein science : a publication of the Protein Society.

[91]  J. Zakrzewska,et al.  Quality of Reporting in Evaluations of Surgical Treatment of Trigeminal Neuralgia: Recommendations for Future Reports , 2003, Neurosurgery.

[92]  Lisa D Howley,et al.  Quality of standardised patient research reports in the medical education literature: review and recommendations , 2008, Medical education.

[93]  World Medical Association (WMA),et al.  Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects , 2009, Journal of the Indian Medical Association.

[94]  Greg Ogrinc,et al.  Publication Guidelines for Quality Improvement Studies in Health Care: Evolution of the SQUIRE Project , 2008, Journal of General Internal Medicine.

[95]  Douglas G Altman,et al.  Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors , 2005, BMJ : British Medical Journal.

[96]  N. Pandis,et al.  A PRISMA assessment of the reporting quality of systematic reviews in orthodontics. , 2013, The Angle orthodontist.

[97]  D. Altman,et al.  Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial , 2011, BMJ : British Medical Journal.

[98]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[99]  A. Silman,et al.  Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. , 1999, The Journal of rheumatology.

[100]  Don C Des Jarlais,et al.  Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. , 2004, American journal of public health.

[101]  C. Weinberg,et al.  Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. , 2002, American journal of epidemiology.

[102]  R. Arnold,et al.  Preschool vision screening: what should we be detecting and how should we report it? Uniform guidelines for reporting results of preschool vision screening studies. , 2003, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[103]  D. Bruns,et al.  Toward a checklist for reporting of studies of diagnostic accuracy of medical tests. , 2000, Clinical chemistry.

[104]  David Moher,et al.  Reducing waste from incomplete or unusable reports of biomedical research , 2014, The Lancet.

[105]  I. Tirodimos,et al.  The quality of safety reporting in trials is still suboptimal: survey of major general medical journals. , 2011, Journal of clinical epidemiology.

[106]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[107]  P. New,et al.  Standardization of data analysis and reporting of results from the International Spinal Cord Injury Core Data Set , 2011, Spinal Cord.

[108]  M. Bhandari,et al.  The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies. , 2007, The Journal of bone and joint surgery. American volume.

[109]  Chris Mason,et al.  International community consensus standard for reporting derivation of human embryonic stem cell lines. , 2007, Regenerative medicine.

[110]  Y. Tu,et al.  Reporting adverse events in randomized controlled trials in periodontology: a systematic review. , 2013, Journal of clinical periodontology.

[111]  R. Willke,et al.  Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[112]  A. Hrõbjartsson,et al.  Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed. , 2011, Journal of clinical epidemiology.

[113]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.

[114]  I. Olkin,et al.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.

[115]  R. Bausell,et al.  Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the consolidated standards of reporting trials (CONSORT). , 2008, Nursing outlook.

[116]  Douglas G Altman,et al.  Epidemiology and reporting of randomised trials published in PubMed journals , 2005, The Lancet.

[117]  T. Wachs,et al.  CONSORT for reporting randomised trials in journal and conference abstracts , 2008 .

[118]  S. Pocock,et al.  Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. , 2006, JAMA.

[119]  D. Altman,et al.  CONSORT statement: extension to cluster randomised trials , 2004, BMJ : British Medical Journal.

[120]  G. Pond,et al.  Improving the Quality of Abstract Reporting for Phase I Cancer Trials , 2008, Clinical Cancer Research.

[121]  D. Moher,et al.  Guidance for Developers of Health Research Reporting Guidelines , 2010, PLoS medicine.

[122]  Nikolaos A Patsopoulos,et al.  Bmc Medical Research Methodology Open Access Reporting of Human Genome Epidemiology (huge) Association Studies: an Empirical Assessment , 2022 .

[123]  D. Moher,et al.  Improving the reporting of pragmatic trials: an extension of the CONSORT statement , 2008, BMJ : British Medical Journal.

[124]  Nicolette de Keizer,et al.  STARE-HI -Statement on Reporting of Evaluation Studies in Health Informatics , 2009, Yearbook of Medical Informatics.

[125]  J. Osborne,et al.  A Proposal for Case Definitions and Outcome Measures in Studies of Infantile Spasms and West Syndrome: Consensus Statement of the West Delphi Group , 2004, Epilepsia.

[126]  D. Moher,et al.  An evaluation of the completeness of safety reporting in reports of complementary and alternative medicine trials , 2011, BMC complementary and alternative medicine.

[127]  David Moher,et al.  Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. , 2008, Annals of internal medicine.

[128]  G. Antes,et al.  Editorial policies of pediatric journals: survey of instructions for authors. , 2010, Archives of pediatrics & adolescent medicine.

[129]  N. Freemantle,et al.  An assessment of the quality of randomised controlled trials conducted in China , 2008, Trials.

[130]  J. Grimshaw,et al.  Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the Theoretical Domains Framework , 2012, Implementation Science.

[131]  Helen M. Moore,et al.  Biospecimen Reporting for Improved Study Quality (BRISQ) , 2013, Transfusion.

[132]  N. Pandis,et al.  Cochrane and non-Cochrane systematic reviews in leading orthodontic journals: a quality paradigm? , 2013, European journal of orthodontics.

[133]  R. Roberts,et al.  Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia. , 2003, American journal of epidemiology.

[134]  H. Völler,et al.  Recommendations for reporting morbid events after heart valve surgery. , 2005, The Journal of heart valve disease.

[135]  David Moher,et al.  Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa , 2012, Systematic Reviews.

[136]  A. D'Amico,et al.  Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[137]  David Moher,et al.  Epidemiology and Reporting Characteristics of Systematic Reviews , 2007, PLoS medicine.

[138]  M. Bhandari,et al.  Overlapping systematic reviews of anterior cruciate ligament reconstruction comparing hamstring autograft with bone-patellar tendon-bone autograft: why are they different? , 2007, The Journal of bone and joint surgery. American volume.

[139]  P Tugwell,et al.  Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. , 2008, Arthritis and rheumatism.

[140]  L. Mantovani,et al.  Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[141]  Paolo Vineis,et al.  STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. , 2011, Preventive medicine.

[142]  D. Moher,et al.  CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.

[143]  P. Granger,et al.  Further Conventions for NMR Shielding and Chemical Shifts (IUPAC Recommendations 2008) , 2008, Magnetic resonance in chemistry : MRC.

[144]  H. Schünemann,et al.  The CONSORT statement checklist in allergen‐specific immunotherapy: a GA2LEN paper , 2009, Allergy.

[145]  Teresa To,et al.  Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. , 2011, Journal of clinical epidemiology.

[146]  M. Drummond,et al.  Evaluating the BMJ guidelines for economic submissions: prospective audit of economic submissions to BMJ and The Lancet. , 1998, JAMA.

[147]  R. Higashida,et al.  Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke , 2003, Stroke.

[148]  E. Romagnoli,et al.  Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study , 2006, BMJ : British Medical Journal.

[149]  American Society for Bariatric Surgery Standards Committee.  Guidelines for Reporting Results in Bariatric Surgery , 1997 .

[150]  A. Azuara-Blanco,et al.  The Quality of Reporting of Diagnostic Accuracy Studies in Glaucoma Using Scanning Laser Polarimetry , 2007, Journal of glaucoma.

[151]  M. Deitel,et al.  Standards for Reporting Results , 1994, Obesity surgery.

[152]  A. Gnekow.  Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology. , 1995, Medical and pediatric oncology.

[153]  Douglas G Altman,et al.  Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. , 2006, JAMA.

[154]  A. Dobson,et al.  RE: “QUALITY OF REPORTING OF OBSERVATIONAL LONGITUDINAL RESEARCH” , 2005 .

[155]  David Atkins,et al.  Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[156]  F. Vermassen,et al.  Standardized definitions and clinical endpoints in carotid artery and supra‐aortic trunk revascularization trials , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[157]  Ben S Cooper,et al.  The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. , 2007, The Lancet. Infectious diseases.

[158]  D. Gustafson,et al.  An Evidence-Based Approach to Interactive Health Communication: A Challenge to Medicine in the Information Age , 1998 .

[159]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[160]  A. Szczepura,et al.  Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies. , 2009, European journal of obstetrics, gynecology, and reproductive biology.